Deep-learning metal artifact reduction achieved sub-3% dose errors in head-and-neck radiotherapy
Retrospective DL-MAR studies achieved dose errors below 3%, but no prospective clinical validation has yet been reported.
Retrospective DL-MAR studies achieved dose errors below 3%, but no prospective clinical validation has yet been reported.
Modeling relationships between CT radiomic features improved distant-metastasis prediction over conventional radiomics across independent head and neck cancer cohorts.
A model integrating planning CT, 3D dose and tumor contours achieved strong external prediction of distant metastasis but weaker local-recurrence performance.
Combined radiomics, foundation-model and clinical features predicted grade ≥2 radiation proctitis with 0.865 AUC on an independent imaging device.
Emission-only PET synthesis produced 0.72% SUVmax bias and 99.2% contrast recovery in an independent NSCLC test cohort.
Task-specific deep learning halved pelvic artifact burden, improved applicator reconstruction to 0.1 mm, and shortened organ contouring by up to 40%.
A model trained at one centre closely predicted doses in 560 head and neck plans from six external institutions.
An autoencoder identified anomalous IMRT plans with an area under the curve of 0.98 and explained which parameters drove each alert.
An MRI and pathology-based model identified a poor-risk oral tongue cancer group in which postoperative radiotherapy was associated with improved survival.
Deep-learning reconstruction produced pancreatic gated cone-beam computed tomography comparable with conventional imaging while reducing estimated acquisition time and imaging dose.
Planning CT features added prognostic information for local and distant control but did not significantly improve overall or progression-free survival prediction.
BiHU-GAN generated synthetic contrast and non-contrast CT with high contour agreement and at least 95% gamma pass rates at 2%/2 mm.
Feature-wise scanning Mamba improved liver radiotherapy segmentation accuracy while reducing model size and inference time.
A conditional generative adversarial network predicted clinically acceptable esophageal radiotherapy dose distributions, but systematic target underdosage limited clinical use.
Synthetic stopping power maps showed small target dose differences, but residual range and low-dose gamma errors still require further validation.